Development and validation of risk prediction models for permanent hypocalcemia after total thyroidectomy in patients with papillary thyroid carcinoma
- PMID: 40102549
- PMCID: PMC11920412
- DOI: 10.1038/s41598-025-93867-9
Development and validation of risk prediction models for permanent hypocalcemia after total thyroidectomy in patients with papillary thyroid carcinoma
Abstract
Hypocalcemia is a common complication and can be permanent in patients following total thyroidectomy (TT). The aim of this study was to identify factors associated with permanent hypocalcemia and to develop a validated risk prediction model for permanent hypocalcemia to assist surgeons in the appropriate follow-up of high-risk patients regarding supplemental therapy. We included data of 92 patients with papillary thyroid carcinoma (PTC) undergoing TT who were randomly allocated in a 7:3 ratio to a training set (n = 65) and validation set (n = 27). Univariate and multivariate logistic regression analyses revealed significant correlations of permanent hypocalcemia with parathyroid hormone (PTH) at postoperative month 1 (IM PTH), IM calcium (Ca), and IM phosphorus (P). These variables were constructed two models. Model 1 used the three indicators listed above; model 2 also included tumor, node, metastasis staging. The receiver operating characteristic (ROC) curve analysis showed that the areas under the curve (AUC) for models 1 and 2 were high for both the training set (0.905/0.913) and the validation set (0.894/0.800). Calibration curves showed good agreement between the incidence of permanent hypocalcemia estimated using the predictive models and the actual incidence. Model 1 may be more concise and convenient for clinical use.
Keywords: Hypocalcemia; Nomogram; Papillary thyroid carcinoma; Predictive model; Total thyroidectomy.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Ethical approval: The study was approved by the Ethics Committee of Benxi Central Hospital of China Medical University. This study adhered to the tenets of the Declaration of Helsinki. This was a retrospective study, and the data used were obtained from the electronic medical records at the hospital, with patient identifiers removed, so that patient privacy and related data would not be disclosed. The study was approved by the ethics committee of our institution, and informed consent was exempted.
Figures








Similar articles
-
The most reliable time point for intact parathyroid hormone measurement to predict hypoparathyroidism after total thyroidectomy with central neck dissection to treat papillary thyroid carcinoma: a prospective cohort study.Eur Arch Otorhinolaryngol. 2020 Feb;277(2):549-558. doi: 10.1007/s00405-019-05693-1. Epub 2019 Oct 16. Eur Arch Otorhinolaryngol. 2020. PMID: 31620890
-
Postoperative Hypoparathyroidism After Total Thyroidectomy in Children.J Surg Res. 2020 Aug;252:63-68. doi: 10.1016/j.jss.2020.02.018. Epub 2020 Mar 29. J Surg Res. 2020. PMID: 32234570
-
Prediction Model of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma.Cancer Control. 2024 Jan-Dec;31:10732748241295347. doi: 10.1177/10732748241295347. Cancer Control. 2024. PMID: 39425895 Free PMC article.
-
Risk factors for the development of hypocalcemia in pediatric patients after total thyroidectomy - A systematic review.Int J Pediatr Otorhinolaryngol. 2021 Apr;143:110666. doi: 10.1016/j.ijporl.2021.110666. Epub 2021 Mar 4. Int J Pediatr Otorhinolaryngol. 2021. PMID: 33706109
-
The effectiveness and safety of prophylactic central neck dissection in clinically node-negative papillary thyroid carcinoma patients: A meta-analysis.Front Endocrinol (Lausanne). 2023 Jan 17;13:1094012. doi: 10.3389/fendo.2022.1094012. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36733809 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical